Department of Internal Medicine, Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan, USA.
Gut Microbes. 2011 Jul-Aug;2(4):211-6. doi: 10.4161/gmic.2.4.17863. Epub 2011 Jul 1.
The worldwide incidence of inflammatory bowel disease (IBD) is increasing. Abundant literature has suggested that an imbalance between harmful and protective bacteria, or dysbiosis, of the intestine is largely responsible for the rising incidence of IBD. In this review, data supporting dysbiosis as a cause of IBD are presented. A comparison of the number of scientific publications in the US versus Europe on intestinal dysbiosis and microbiota revealed the US scientific community has a lower level of interest in studying dysbiosis and microbiota compared the research community in Europe. The rising trend of antibiotic use in the US provides further evidence of the lack of concern for the effect of dysbiosis on human health. Further research to understand the causal relationship between dysbiosis and IBD are needed to better guide clinical practice in using probiotics.
炎症性肠病(IBD)的全球发病率正在上升。大量文献表明,肠道内有害菌和有益菌之间的失衡,即肠道菌群失调,在很大程度上是导致 IBD 发病率上升的原因。在这篇综述中,我们提出了肠道菌群失调是 IBD 病因的相关数据。美国和欧洲在肠道菌群失调和微生物组方面的科学出版物数量比较表明,与欧洲的研究界相比,美国科学界对研究菌群失调和微生物组的兴趣较低。美国抗生素使用量的上升趋势进一步证明了人们对菌群失调对人类健康影响的关注不足。需要进一步研究以了解菌群失调与 IBD 之间的因果关系,从而更好地指导临床实践中使用益生菌。